Jove
Visualize
联系我们

相关概念视频

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Highlights from the 2025 Symposium of the Collegium Internationale Allergologicum.

The Journal of allergy and clinical immunology·2026
Same author

Upper airway microbiome interacts with GSDMB and ORMDL3 asthma risk SNPs to influence early-life wheeze risk.

The Journal of allergy and clinical immunology·2026
Same author

Azithromycin for Preschoolers with Wheezing in the Emergency Department.

The New England journal of medicine·2026
Same author

Multicohort analysis unveils axon guidance pathways linking small for gestational age to spirometric restriction.

Nature communications·2026
Same author

Profiling Peripheral Blood with an Optimized, Multiplexed, Single-cell Multiome Approach Supports an Insulin-driven Asthma Subtype.

bioRxiv : the preprint server for biology·2026
Same author

PrecISE-a biomarker-stratified adaptive trial of 5 interventions in severe asthma: Final protocol and the baseline cohort.

The Journal of allergy and clinical immunology·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
查看所有相关文章
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: May 7, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

喘 喘 是一种

Fernando D Martinez1, Donata Vercelli

  • 1Arizona Respiratory Center and BIO5 Institute, University of Arizona, Tucson, AZ, USA.

Lancet (London, England)
|September 18, 2013
PubMed
概括
此摘要是机器生成的。

喘涉及可逆性呼吸道阻塞,通常从童年开始,有遗传联系. 早期的微生物暴露可以预防喘,而新的生物疗法为严重病例提供了希望.

更多相关视频

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

相关实验视频

Last Updated: May 7, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

科学领域:

  • 肺部病理学 肺部病理学
  • 遗传学 是一个遗传学.
  • 免疫学 免疫学 免疫学

背景情况:

  • 喘是一种复杂的呼吸系统疾病,其特点是经常出现,可逆的支气管阻塞,经常在童年开始.
  • 遗传因素起着重要作用,鉴定出的基因变异增加了喘风险.
  • 与病毒感染和改变的呼吸道微生物群的关联被注意到,但它们的因果作用仍然不清楚.

研究的目的:

  • 探索喘的发病因子,重点关注遗传和免疫因素.
  • 调查潜在的预防策略,特别是早期的微生物暴露.
  • 审查当前和新兴的治疗方法来治疗轻度,中度和重度喘.

主要方法:

  • 对遗传研究的审查,包括全基因组关联研究 (GWAS).
  • 分析免疫学数据,涉及肺部常驻细胞和粘膜表皮.
  • 对早期环境暴露的流行病学发现的审查.
  • 评估当前治疗指南和新兴的生物疗法.

主要成果:

  • 遗传变异有助于喘易感性.
  • 早期接触微生物产品,特别是在农业环境中,显示出保护作用.
  • 缺陷的肺部居民细胞反应是喘发病的关键.
  • 吸入性皮质类固醇是轻度至中度喘的标准,但坚持是具有挑战性的.
  • 针对IgE,IL-5和IL-13的生物疗法在严重的耐火性喘中显示出前景.

结论:

  • 喘病原包括遗传倾向和免疫失调.
  • 生命早期的环境暴露可能提供一种新的预防途径.
  • 吸入性皮质类固醇的坚持仍然是一个治疗障碍.
  • 有针对性的生物疗法代表了严重喘管理的重大进步.